nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.101	0.182	CbGbCtD
Dorzolamide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.101	0.182	CbGbCtD
Dorzolamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0777	0.14	CbGbCtD
Dorzolamide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0767	0.138	CbGbCtD
Dorzolamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0525	0.0946	CbGbCtD
Dorzolamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0501	0.0902	CbGbCtD
Dorzolamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0446	0.0804	CbGbCtD
Dorzolamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0262	0.0472	CbGbCtD
Dorzolamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0247	0.0445	CbGbCtD
Dorzolamide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.000853	0.022	CbGpPWpGaD
Dorzolamide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.000791	0.0204	CbGpPWpGaD
Dorzolamide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000776	0.02	CbGpPWpGaD
Dorzolamide—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000738	0.00184	CcSEcCtD
Dorzolamide—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000738	0.00184	CcSEcCtD
Dorzolamide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000738	0.00184	CcSEcCtD
Dorzolamide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000733	0.00183	CcSEcCtD
Dorzolamide—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000723	0.0018	CcSEcCtD
Dorzolamide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000719	0.00179	CcSEcCtD
Dorzolamide—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000715	0.00178	CcSEcCtD
Dorzolamide—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000714	0.00178	CcSEcCtD
Dorzolamide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000714	0.00178	CcSEcCtD
Dorzolamide—CA1—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.00071	0.0183	CbGpPWpGaD
Dorzolamide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000708	0.00177	CcSEcCtD
Dorzolamide—Cough—Formoterol—chronic obstructive pulmonary disease	0.000705	0.00176	CcSEcCtD
Dorzolamide—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000705	0.00176	CcSEcCtD
Dorzolamide—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000699	0.00174	CcSEcCtD
Dorzolamide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000697	0.00174	CcSEcCtD
Dorzolamide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000697	0.00174	CcSEcCtD
Dorzolamide—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.00174	CcSEcCtD
Dorzolamide—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000691	0.00172	CcSEcCtD
Dorzolamide—Cough—Montelukast—chronic obstructive pulmonary disease	0.00069	0.00172	CcSEcCtD
Dorzolamide—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000688	0.00172	CcSEcCtD
Dorzolamide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000688	0.00172	CcSEcCtD
Dorzolamide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000688	0.00171	CcSEcCtD
Dorzolamide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000688	0.00171	CcSEcCtD
Dorzolamide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000688	0.00171	CcSEcCtD
Dorzolamide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000688	0.00171	CcSEcCtD
Dorzolamide—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000685	0.00171	CcSEcCtD
Dorzolamide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000685	0.00171	CcSEcCtD
Dorzolamide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00171	CcSEcCtD
Dorzolamide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000685	0.00171	CcSEcCtD
Dorzolamide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000685	0.00171	CcSEcCtD
Dorzolamide—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000684	0.00171	CcSEcCtD
Dorzolamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000679	0.00169	CcSEcCtD
Dorzolamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000679	0.00169	CcSEcCtD
Dorzolamide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000674	0.00168	CcSEcCtD
Dorzolamide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000673	0.00168	CcSEcCtD
Dorzolamide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000672	0.00168	CcSEcCtD
Dorzolamide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000672	0.00168	CcSEcCtD
Dorzolamide—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000671	0.00167	CcSEcCtD
Dorzolamide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00067	0.00167	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000668	0.00167	CcSEcCtD
Dorzolamide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.00166	CcSEcCtD
Dorzolamide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000659	0.00164	CcSEcCtD
Dorzolamide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000659	0.00164	CcSEcCtD
Dorzolamide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000659	0.00164	CcSEcCtD
Dorzolamide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000659	0.00164	CcSEcCtD
Dorzolamide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000658	0.00164	CcSEcCtD
Dorzolamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000649	0.00162	CcSEcCtD
Dorzolamide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000649	0.00162	CcSEcCtD
Dorzolamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000649	0.00162	CcSEcCtD
Dorzolamide—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000647	0.00161	CcSEcCtD
Dorzolamide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000647	0.00161	CcSEcCtD
Dorzolamide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000646	0.00161	CcSEcCtD
Dorzolamide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000646	0.00161	CcSEcCtD
Dorzolamide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000646	0.00161	CcSEcCtD
Dorzolamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000641	0.0016	CcSEcCtD
Dorzolamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000638	0.00159	CcSEcCtD
Dorzolamide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000635	0.00158	CcSEcCtD
Dorzolamide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000626	0.0161	CbGpPWpGaD
Dorzolamide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000622	0.00155	CcSEcCtD
Dorzolamide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000622	0.00155	CcSEcCtD
Dorzolamide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00062	0.016	CbGpPWpGaD
Dorzolamide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000616	0.00154	CcSEcCtD
Dorzolamide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000616	0.00154	CcSEcCtD
Dorzolamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000613	0.00153	CcSEcCtD
Dorzolamide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000612	0.00153	CcSEcCtD
Dorzolamide—CA7—trachea—chronic obstructive pulmonary disease	0.000602	0.116	CbGeAlD
Dorzolamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000602	0.0015	CcSEcCtD
Dorzolamide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000602	0.0015	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000601	0.0015	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.0015	CcSEcCtD
Dorzolamide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00149	CcSEcCtD
Dorzolamide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00149	CcSEcCtD
Dorzolamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000593	0.00148	CcSEcCtD
Dorzolamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000593	0.00148	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00147	CcSEcCtD
Dorzolamide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000588	0.00147	CcSEcCtD
Dorzolamide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000588	0.00147	CcSEcCtD
Dorzolamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000586	0.00146	CcSEcCtD
Dorzolamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000586	0.00146	CcSEcCtD
Dorzolamide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000584	0.00146	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000582	0.00145	CcSEcCtD
Dorzolamide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.00145	CcSEcCtD
Dorzolamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00058	0.00145	CcSEcCtD
Dorzolamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00058	0.00145	CcSEcCtD
Dorzolamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00058	0.00145	CcSEcCtD
Dorzolamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000578	0.00144	CcSEcCtD
Dorzolamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000574	0.00143	CcSEcCtD
Dorzolamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000573	0.00143	CcSEcCtD
Dorzolamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000568	0.00142	CcSEcCtD
Dorzolamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00142	CcSEcCtD
Dorzolamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00142	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000567	0.00141	CcSEcCtD
Dorzolamide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000564	0.0145	CbGpPWpGaD
Dorzolamide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000564	0.00141	CcSEcCtD
Dorzolamide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000564	0.00141	CcSEcCtD
Dorzolamide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.0014	CcSEcCtD
Dorzolamide—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000562	0.0014	CcSEcCtD
Dorzolamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.00139	CcSEcCtD
Dorzolamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000557	0.00139	CcSEcCtD
Dorzolamide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00138	CcSEcCtD
Dorzolamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000553	0.00138	CcSEcCtD
Dorzolamide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000552	0.00138	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000552	0.00138	CcSEcCtD
Dorzolamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000551	0.00137	CcSEcCtD
Dorzolamide—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000549	0.00137	CcSEcCtD
Dorzolamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00137	CcSEcCtD
Dorzolamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000546	0.00136	CcSEcCtD
Dorzolamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000546	0.00136	CcSEcCtD
Dorzolamide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000544	0.00136	CcSEcCtD
Dorzolamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000543	0.00135	CcSEcCtD
Dorzolamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000543	0.00135	CcSEcCtD
Dorzolamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000543	0.00135	CcSEcCtD
Dorzolamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.00135	CcSEcCtD
Dorzolamide—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000541	0.00135	CcSEcCtD
Dorzolamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00054	0.00135	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000539	0.00134	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000539	0.00134	CcSEcCtD
Dorzolamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000537	0.00134	CcSEcCtD
Dorzolamide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000532	0.00133	CcSEcCtD
Dorzolamide—CA12—respiratory system—chronic obstructive pulmonary disease	0.000529	0.102	CbGeAlD
Dorzolamide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000528	0.00132	CcSEcCtD
Dorzolamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.00131	CcSEcCtD
Dorzolamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000524	0.00131	CcSEcCtD
Dorzolamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.0013	CcSEcCtD
Dorzolamide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000521	0.0013	CcSEcCtD
Dorzolamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000521	0.0013	CcSEcCtD
Dorzolamide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.0013	CcSEcCtD
Dorzolamide—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000519	0.0013	CcSEcCtD
Dorzolamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00129	CcSEcCtD
Dorzolamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.00128	CcSEcCtD
Dorzolamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000514	0.00128	CcSEcCtD
Dorzolamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000514	0.00128	CcSEcCtD
Dorzolamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000513	0.00128	CcSEcCtD
Dorzolamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00128	CcSEcCtD
Dorzolamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000512	0.00128	CcSEcCtD
Dorzolamide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000511	0.00128	CcSEcCtD
Dorzolamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00051	0.00127	CcSEcCtD
Dorzolamide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00051	0.00127	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000509	0.00127	CcSEcCtD
Dorzolamide—CA9—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000508	0.0131	CbGpPWpGaD
Dorzolamide—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000502	0.00125	CcSEcCtD
Dorzolamide—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.0005	0.00125	CcSEcCtD
Dorzolamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.00123	CcSEcCtD
Dorzolamide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00123	CcSEcCtD
Dorzolamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00123	CcSEcCtD
Dorzolamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00121	CcSEcCtD
Dorzolamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00121	CcSEcCtD
Dorzolamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000485	0.00121	CcSEcCtD
Dorzolamide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000484	0.00121	CcSEcCtD
Dorzolamide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00048	0.0124	CbGpPWpGaD
Dorzolamide—CA9—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000479	0.0123	CbGpPWpGaD
Dorzolamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00119	CcSEcCtD
Dorzolamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.00118	CcSEcCtD
Dorzolamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000473	0.00118	CcSEcCtD
Dorzolamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000466	0.00116	CcSEcCtD
Dorzolamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000466	0.00116	CcSEcCtD
Dorzolamide—CA12—connective tissue—chronic obstructive pulmonary disease	0.000466	0.0895	CbGeAlD
Dorzolamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00115	CcSEcCtD
Dorzolamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00114	CcSEcCtD
Dorzolamide—CA9—Cellular response to hypoxia—VEGFA—chronic obstructive pulmonary disease	0.000457	0.0118	CbGpPWpGaD
Dorzolamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000457	0.00114	CcSEcCtD
Dorzolamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000451	0.00112	CcSEcCtD
Dorzolamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000451	0.00112	CcSEcCtD
Dorzolamide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000449	0.00112	CcSEcCtD
Dorzolamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00111	CcSEcCtD
Dorzolamide—CA1—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000444	0.0114	CbGpPWpGaD
Dorzolamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000442	0.0011	CcSEcCtD
Dorzolamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00044	0.0011	CcSEcCtD
Dorzolamide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000437	0.00109	CcSEcCtD
Dorzolamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00109	CcSEcCtD
Dorzolamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00109	CcSEcCtD
Dorzolamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00106	CcSEcCtD
Dorzolamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.00106	CcSEcCtD
Dorzolamide—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00042	0.00105	CcSEcCtD
Dorzolamide—CA1—respiratory system—chronic obstructive pulmonary disease	0.000419	0.0805	CbGeAlD
Dorzolamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00104	CcSEcCtD
Dorzolamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00104	CcSEcCtD
Dorzolamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00104	CcSEcCtD
Dorzolamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00104	CcSEcCtD
Dorzolamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000415	0.00104	CcSEcCtD
Dorzolamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000415	0.00104	CcSEcCtD
Dorzolamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00103	CcSEcCtD
Dorzolamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00103	CcSEcCtD
Dorzolamide—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00103	CcSEcCtD
Dorzolamide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000412	0.00103	CcSEcCtD
Dorzolamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00103	CcSEcCtD
Dorzolamide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000411	0.00103	CcSEcCtD
Dorzolamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00102	CcSEcCtD
Dorzolamide—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00041	0.0106	CbGpPWpGaD
Dorzolamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00101	CcSEcCtD
Dorzolamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00101	CcSEcCtD
Dorzolamide—Depression—Prednisone—chronic obstructive pulmonary disease	0.000406	0.00101	CcSEcCtD
Dorzolamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000404	0.00101	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000401	0.001	CcSEcCtD
Dorzolamide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.0004	0.000997	CcSEcCtD
Dorzolamide—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000399	0.000994	CcSEcCtD
Dorzolamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.000987	CcSEcCtD
Dorzolamide—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000394	0.0102	CbGpPWpGaD
Dorzolamide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000393	0.00098	CcSEcCtD
Dorzolamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.000978	CcSEcCtD
Dorzolamide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000392	0.000978	CcSEcCtD
Dorzolamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.000978	CcSEcCtD
Dorzolamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000392	0.000976	CcSEcCtD
Dorzolamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.000976	CcSEcCtD
Dorzolamide—CA12—trachea—chronic obstructive pulmonary disease	0.000391	0.0751	CbGeAlD
Dorzolamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.000972	CcSEcCtD
Dorzolamide—CA9—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000389	0.01	CbGpPWpGaD
Dorzolamide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000384	0.000959	CcSEcCtD
Dorzolamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000383	0.000956	CcSEcCtD
Dorzolamide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000378	0.000942	CcSEcCtD
Dorzolamide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000372	0.00959	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	0.000372	0.00958	CbGpPWpGaD
Dorzolamide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000372	0.000927	CcSEcCtD
Dorzolamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.000922	CcSEcCtD
Dorzolamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000368	0.000917	CcSEcCtD
Dorzolamide—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000906	CcSEcCtD
Dorzolamide—CA9—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000363	0.00935	CbGpPWpGaD
Dorzolamide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000357	0.00089	CcSEcCtD
Dorzolamide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000357	0.00089	CcSEcCtD
Dorzolamide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.000876	CcSEcCtD
Dorzolamide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.00086	CcSEcCtD
Dorzolamide—CA4—respiratory system—chronic obstructive pulmonary disease	0.000328	0.0629	CbGeAlD
Dorzolamide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000813	CcSEcCtD
Dorzolamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000323	0.00833	CbGpPWpGaD
Dorzolamide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000323	0.000805	CcSEcCtD
Dorzolamide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000804	CcSEcCtD
Dorzolamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.000799	CcSEcCtD
Dorzolamide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000318	0.000792	CcSEcCtD
Dorzolamide—CA14—Metabolism—APIP—chronic obstructive pulmonary disease	0.000309	0.00796	CbGpPWpGaD
Dorzolamide—CA9—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000306	0.00788	CbGpPWpGaD
Dorzolamide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000305	0.000761	CcSEcCtD
Dorzolamide—CA6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000301	0.00776	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000301	0.00776	CbGpPWpGaD
Dorzolamide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.0003	0.000747	CcSEcCtD
Dorzolamide—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000298	0.00767	CbGpPWpGaD
Dorzolamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.000733	CcSEcCtD
Dorzolamide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000294	0.00758	CbGpPWpGaD
Dorzolamide—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00029	0.000724	CcSEcCtD
Dorzolamide—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000286	0.00738	CbGpPWpGaD
Dorzolamide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000712	CcSEcCtD
Dorzolamide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000285	0.000711	CcSEcCtD
Dorzolamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.000707	CcSEcCtD
Dorzolamide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000281	0.00726	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000281	0.00724	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—APIP—chronic obstructive pulmonary disease	0.000281	0.00724	CbGpPWpGaD
Dorzolamide—CA12—lung—chronic obstructive pulmonary disease	0.000281	0.054	CbGeAlD
Dorzolamide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000279	0.000697	CcSEcCtD
Dorzolamide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000684	CcSEcCtD
Dorzolamide—CA2—respiratory system—chronic obstructive pulmonary disease	0.000272	0.0522	CbGeAlD
Dorzolamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000675	CcSEcCtD
Dorzolamide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00027	0.00697	CbGpPWpGaD
Dorzolamide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000672	CcSEcCtD
Dorzolamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000268	0.00691	CbGpPWpGaD
Dorzolamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000667	CcSEcCtD
Dorzolamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.000656	CcSEcCtD
Dorzolamide—CA12—Metabolism—APIP—chronic obstructive pulmonary disease	0.00026	0.00671	CbGpPWpGaD
Dorzolamide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00026	0.0067	CbGpPWpGaD
Dorzolamide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000647	CcSEcCtD
Dorzolamide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000647	CcSEcCtD
Dorzolamide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000636	CcSEcCtD
Dorzolamide—CA5B—lung—chronic obstructive pulmonary disease	0.000252	0.0484	CbGeAlD
Dorzolamide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000625	CcSEcCtD
Dorzolamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000247	0.000617	CcSEcCtD
Dorzolamide—CA4—trachea—chronic obstructive pulmonary disease	0.000242	0.0465	CbGeAlD
Dorzolamide—CA2—connective tissue—chronic obstructive pulmonary disease	0.000239	0.0459	CbGeAlD
Dorzolamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000589	CcSEcCtD
Dorzolamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.000589	CcSEcCtD
Dorzolamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000235	0.00605	CbGpPWpGaD
Dorzolamide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000585	CcSEcCtD
Dorzolamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000581	CcSEcCtD
Dorzolamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000569	CcSEcCtD
Dorzolamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000562	CcSEcCtD
Dorzolamide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000225	0.00581	CbGpPWpGaD
Dorzolamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000561	CcSEcCtD
Dorzolamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000561	CcSEcCtD
Dorzolamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000558	CcSEcCtD
Dorzolamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.000558	CcSEcCtD
Dorzolamide—CA2—bronchus—chronic obstructive pulmonary disease	0.000224	0.0429	CbGeAlD
Dorzolamide—CA1—lung—chronic obstructive pulmonary disease	0.000223	0.0428	CbGeAlD
Dorzolamide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000219	0.042	CbGeAlD
Dorzolamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000533	CcSEcCtD
Dorzolamide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000214	0.00551	CbGpPWpGaD
Dorzolamide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000529	CcSEcCtD
Dorzolamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.000529	CcSEcCtD
Dorzolamide—CA9—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.00021	0.00542	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000208	0.00535	CbGpPWpGaD
Dorzolamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000514	CcSEcCtD
Dorzolamide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000511	CcSEcCtD
Dorzolamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000511	CcSEcCtD
Dorzolamide—CA14—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000205	0.00527	CbGpPWpGaD
Dorzolamide—CA2—trachea—chronic obstructive pulmonary disease	0.000201	0.0386	CbGeAlD
Dorzolamide—CA6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000199	0.00514	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000199	0.00514	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000199	0.00513	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—GC—chronic obstructive pulmonary disease	0.000199	0.00513	CbGpPWpGaD
Dorzolamide—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.00507	CbGpPWpGaD
Dorzolamide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000196	0.00506	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GC—chronic obstructive pulmonary disease	0.000194	0.005	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GC—chronic obstructive pulmonary disease	0.000194	0.005	CbGpPWpGaD
Dorzolamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000477	CcSEcCtD
Dorzolamide—CA1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000191	0.00492	CbGpPWpGaD
Dorzolamide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000189	0.00487	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000186	0.0048	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000186	0.0048	CbGpPWpGaD
Dorzolamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000464	CcSEcCtD
Dorzolamide—CA14—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000185	0.00477	CbGpPWpGaD
Dorzolamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000458	CcSEcCtD
Dorzolamide—CA7—Metabolism—GC—chronic obstructive pulmonary disease	0.000181	0.00467	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GC—chronic obstructive pulmonary disease	0.000181	0.00467	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00018	0.00465	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00018	0.00465	CbGpPWpGaD
Dorzolamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000443	CcSEcCtD
Dorzolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00456	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000174	0.00449	CbGpPWpGaD
Dorzolamide—CA4—lung—chronic obstructive pulmonary disease	0.000174	0.0334	CbGeAlD
Dorzolamide—CA12—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000172	0.00445	CbGpPWpGaD
Dorzolamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000428	CcSEcCtD
Dorzolamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00017	0.00439	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.00017	0.00438	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000168	0.00434	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000168	0.00434	CbGpPWpGaD
Dorzolamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00433	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000168	0.00432	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GC—chronic obstructive pulmonary disease	0.000168	0.00432	CbGpPWpGaD
Dorzolamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000411	CcSEcCtD
Dorzolamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000408	CcSEcCtD
Dorzolamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000407	CcSEcCtD
Dorzolamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000405	CcSEcCtD
Dorzolamide—CA12—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000156	0.00402	CbGpPWpGaD
Dorzolamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000384	CcSEcCtD
Dorzolamide—CA2—lung—chronic obstructive pulmonary disease	0.000144	0.0277	CbGeAlD
Dorzolamide—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.00369	CbGpPWpGaD
Dorzolamide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.00358	CbGpPWpGaD
Dorzolamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00356	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000138	0.00355	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GC—chronic obstructive pulmonary disease	0.000134	0.00345	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000132	0.0034	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GC—chronic obstructive pulmonary disease	0.000128	0.00331	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000126	0.00326	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000124	0.00321	CbGpPWpGaD
Dorzolamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00319	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GC—chronic obstructive pulmonary disease	0.000123	0.00317	CbGpPWpGaD
Dorzolamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00314	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000119	0.00307	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000115	0.00296	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000114	0.00295	CbGpPWpGaD
Dorzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00289	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000111	0.00286	CbGpPWpGaD
Dorzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00285	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000109	0.0028	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GC—chronic obstructive pulmonary disease	0.000108	0.00279	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000107	0.00277	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000106	0.00273	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000106	0.00273	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000105	0.0027	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000105	0.0027	CbGpPWpGaD
Dorzolamide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.0026	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.0001	0.00259	CbGpPWpGaD
Dorzolamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00258	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.89e-05	0.00255	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.89e-05	0.00255	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CTGF—chronic obstructive pulmonary disease	9.81e-05	0.00253	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GCLC—chronic obstructive pulmonary disease	9.78e-05	0.00252	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GCLC—chronic obstructive pulmonary disease	9.78e-05	0.00252	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CTGF—chronic obstructive pulmonary disease	9.56e-05	0.00246	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.56e-05	0.00246	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.16e-05	0.00236	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.09e-05	0.00234	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GCLC—chronic obstructive pulmonary disease	9.06e-05	0.00234	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.04e-05	0.00233	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CTGF—chronic obstructive pulmonary disease	8.92e-05	0.0023	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CTGF—chronic obstructive pulmonary disease	8.92e-05	0.0023	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.81e-05	0.00227	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.81e-05	0.00227	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.81e-05	0.00227	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.71e-05	0.00225	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	8.54e-05	0.0022	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CTGF—chronic obstructive pulmonary disease	8.27e-05	0.00213	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.22e-05	0.00212	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.22e-05	0.00212	CbGpPWpGaD
Dorzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.15e-05	0.0021	CbGpPWpGaD
Dorzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.04e-05	0.00207	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.62e-05	0.00196	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.54e-05	0.00194	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.43e-05	0.00192	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.34e-05	0.00189	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.34e-05	0.00189	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.33e-05	0.00189	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.31e-05	0.00188	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.24e-05	0.00187	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.24e-05	0.00187	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.22e-05	0.00186	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.22e-05	0.00186	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.01e-05	0.00181	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	6.93e-05	0.00179	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.93e-05	0.00179	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.93e-05	0.00179	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.86e-05	0.00177	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.86e-05	0.00177	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.76e-05	0.00174	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.76e-05	0.00174	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.75e-05	0.00174	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.75e-05	0.00174	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.72e-05	0.00173	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.64e-05	0.00171	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.61e-05	0.0017	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.59e-05	0.0017	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.57e-05	0.00169	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.4e-05	0.00165	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.4e-05	0.00165	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.35e-05	0.00164	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.32e-05	0.00163	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.3e-05	0.00162	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.3e-05	0.00162	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.26e-05	0.00162	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.2e-05	0.0016	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.11e-05	0.00158	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.07e-05	0.00157	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.06e-05	0.00156	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.03e-05	0.00155	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.97e-05	0.00154	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.97e-05	0.00154	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.91e-05	0.00152	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	5.84e-05	0.0015	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.84e-05	0.0015	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.82e-05	0.0015	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.81e-05	0.0015	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.75e-05	0.00148	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.61e-05	0.00145	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.58e-05	0.00144	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.54e-05	0.00143	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.53e-05	0.00143	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.33e-05	0.00137	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.32e-05	0.00137	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.25e-05	0.00135	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	5.24e-05	0.00135	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.07e-05	0.00131	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5e-05	0.00129	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.91e-05	0.00127	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.86e-05	0.00125	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.83e-05	0.00125	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	4.8e-05	0.00124	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.79e-05	0.00123	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.76e-05	0.00123	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.66e-05	0.0012	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.66e-05	0.0012	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.59e-05	0.00118	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.46e-05	0.00115	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ALB—chronic obstructive pulmonary disease	4.46e-05	0.00115	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.41e-05	0.00114	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ALB—chronic obstructive pulmonary disease	4.35e-05	0.00112	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	4.35e-05	0.00112	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	4.28e-05	0.0011	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.28e-05	0.0011	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—NOS3—chronic obstructive pulmonary disease	4.27e-05	0.0011	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.23e-05	0.00109	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	4.16e-05	0.00107	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.16e-05	0.00107	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.09e-05	0.00106	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	4.06e-05	0.00105	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	4.06e-05	0.00105	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.06e-05	0.00105	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.04e-05	0.00104	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.03e-05	0.00104	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.97e-05	0.00102	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	3.88e-05	0.001	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	3.88e-05	0.001	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.76e-05	0.00097	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	3.76e-05	0.00097	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.7e-05	0.000955	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.65e-05	0.000941	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	3.6e-05	0.000928	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.57e-05	0.000919	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.51e-05	0.000905	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.46e-05	0.000893	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.05e-05	0.000787	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	3e-05	0.000773	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	2.88e-05	0.000741	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.87e-05	0.00074	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.84e-05	0.000731	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.82e-05	0.000728	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.81e-05	0.000725	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.76e-05	0.000711	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALB—chronic obstructive pulmonary disease	2.76e-05	0.000711	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.75e-05	0.000709	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.64e-05	0.00068	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.57e-05	0.000661	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	2.42e-05	0.000625	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.32e-05	0.000598	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.04e-05	0.000527	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.87e-05	0.000482	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.82e-05	0.000469	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.69e-05	0.000436	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.51e-05	0.000389	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.49e-05	0.000384	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000358	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.36e-05	0.000351	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.25e-05	0.000323	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.000269	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-05	0.000266	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.94e-06	0.000256	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.83e-06	0.000253	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.6e-06	0.000248	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.1e-06	0.000235	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.97e-06	0.000231	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.26e-06	0.000213	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.89e-06	0.000178	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.8e-06	0.000175	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.33e-06	0.000163	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	6.19e-06	0.00016	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6e-06	0.000155	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.92e-06	0.000153	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.08e-06	0.000105	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.9e-06	0.000101	CbGpPWpGaD
